Home
>
National Drug Code (NDC)
>
carisoprodol
carisoprodol - 65862-158-01 - (carisoprodol)
Drug Information of carisoprodol
| Product NDC: | 65862-158 |
| Proprietary Name: | carisoprodol |
| Non Proprietary Name: | carisoprodol |
| Active Ingredient(s): | 350 mg/1 & nbsp; carisoprodol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of carisoprodol
| Product NDC: | 65862-158 |
| Labeler Name: | Aurobindo Pharma Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040792 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090806 |
Package Information of carisoprodol
| Package NDC: | 65862-158-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (65862-158-01) |
NDC Information of carisoprodol
| NDC Code | 65862-158-01 |
| Proprietary Name | carisoprodol |
| Package Description | 100 TABLET in 1 BOTTLE (65862-158-01) |
| Product NDC | 65862-158 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | carisoprodol |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090806 |
| Marketing Category Name | ANDA |
| Labeler Name | Aurobindo Pharma Limited |
| Substance Name | CARISOPRODOL |
| Strength Number | 350 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |
